JP2012518669A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012518669A5 JP2012518669A5 JP2011551471A JP2011551471A JP2012518669A5 JP 2012518669 A5 JP2012518669 A5 JP 2012518669A5 JP 2011551471 A JP2011551471 A JP 2011551471A JP 2011551471 A JP2011551471 A JP 2011551471A JP 2012518669 A5 JP2012518669 A5 JP 2012518669A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- amino acids
- surface active
- natural
- active protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000018102 proteins Nutrition 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 3
- 235000001014 amino acid Nutrition 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 150000001945 cysteines Chemical class 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- 235000004400 serine Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09153770.4 | 2009-02-26 | ||
| EP09153770 | 2009-02-26 | ||
| PCT/EP2010/052125 WO2010097344A1 (en) | 2009-02-26 | 2010-02-19 | Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012518669A JP2012518669A (ja) | 2012-08-16 |
| JP2012518669A5 true JP2012518669A5 (enExample) | 2014-07-31 |
| JP5832302B2 JP5832302B2 (ja) | 2015-12-16 |
Family
ID=40834317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011551471A Expired - Fee Related JP5832302B2 (ja) | 2009-02-26 | 2010-02-19 | ケラチンへの局所薬剤デリバリーにおける表面活性タンパク質の組成物、使用及び使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8758730B2 (enExample) |
| EP (1) | EP2400988B1 (enExample) |
| JP (1) | JP5832302B2 (enExample) |
| KR (1) | KR20110130440A (enExample) |
| CN (1) | CN102333546B (enExample) |
| CA (1) | CA2784516C (enExample) |
| WO (1) | WO2010097344A1 (enExample) |
| ZA (1) | ZA201203028B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013113451A2 (en) * | 2012-01-31 | 2013-08-08 | Unilever Plc | Personal care composition |
| WO2014028422A1 (en) * | 2012-08-16 | 2014-02-20 | Dusa Pharmaceuticals, Inc. | Method of treating onychomycosis |
| CN103980353A (zh) * | 2014-05-21 | 2014-08-13 | 乔明强 | 一种疏水蛋白及其组成的药物制剂 |
| RU2759134C2 (ru) * | 2015-10-26 | 2021-11-09 | Басф Се | Продукты и способы для ухода за полостью рта, содержащие hlp |
| CN112198315B (zh) * | 2020-09-11 | 2023-10-27 | 杭州奥泰生物技术股份有限公司 | 一种采集及检测指甲或趾甲样本中滥用药物的方法 |
| CN112791048B (zh) * | 2020-12-31 | 2023-01-17 | 海南海神同洲制药有限公司 | 一种硝酸舍他康唑栓及其制备方法 |
| CN115701464B (zh) * | 2021-08-02 | 2024-06-11 | 江苏金太阳纺织科技股份有限公司 | 超疏水整理剂及其制备方法与应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3807915A1 (de) * | 1988-03-10 | 1989-09-21 | Wella Ag | Mittel zur festigung der frisur und pflege des haares |
| FR2673537B1 (fr) | 1991-03-08 | 1993-06-11 | Oreal | Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes. |
| WO1996041882A1 (en) | 1995-06-12 | 1996-12-27 | Proefstation Voor De Champignoncultuur | Hydrophobins from edible fungi, genes, nucleotide sequences and dna-fragments encoding for said hydrophobins, and expression thereof |
| EP0866683A4 (en) | 1995-09-14 | 1999-01-07 | Sorenson Pharmaceutical Inc | MEANS AND METHOD FOR TREATING DISEASE NAILS |
| JP4227677B2 (ja) * | 1996-12-10 | 2009-02-18 | 杏林製薬株式会社 | 被膜形成性抗真菌剤組成物 |
| US6517863B1 (en) * | 1999-01-20 | 2003-02-11 | Usbiomaterials Corporation | Compositions and methods for treating nails and adjacent tissues |
| GB0019283D0 (en) | 2000-08-04 | 2000-09-27 | Novartis Ag | Organic compounds |
| FR2833490B1 (fr) | 2001-12-14 | 2004-12-10 | Oreal | Utilisition cosmetique d'au moins une hydrophobine pour le traitement des matieres keratiniques et compositions mises en oeuvre |
| US6899890B2 (en) * | 2002-03-20 | 2005-05-31 | Kv Pharmaceutical Company | Bioadhesive drug delivery system |
| WO2004000880A1 (en) | 2002-06-21 | 2003-12-31 | Applied Nanosystems B.V. | Method of binding a compound to a surface |
| JP5250264B2 (ja) | 2005-02-07 | 2013-07-31 | ビーエーエスエフ ソシエタス・ヨーロピア | 新規ハイドロフォビン融合タンパク質、その製造および使用 |
| WO2006103230A1 (de) | 2005-03-30 | 2006-10-05 | Basf Aktiengesellschaft | Verwendung von hydrophobinen zur oberflächenbehandlung von gehärteten mineralischen baustoffen, naturstein, kunststein und keramiken |
| WO2006103638A2 (en) | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Topical pharmaceutical compositions of terbinafine and processes for their preparation |
| CN101151081B (zh) | 2005-04-01 | 2012-02-29 | 巴斯福股份公司 | 蛋白质作为破乳剂的用途 |
| DE102005029704A1 (de) * | 2005-06-24 | 2007-01-11 | Basf Ag | Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik |
| DE102005033002A1 (de) | 2005-07-14 | 2007-01-18 | Basf Ag | Wässrige Monomeremulsionen enthaltend Hydrophobin |
| FR2892023B1 (fr) | 2005-10-14 | 2009-09-25 | Galderma Sa | Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale |
| CA2687490A1 (en) | 2007-05-24 | 2008-11-27 | Basf Se | Use of hydrophobins as auxiliaries in the crystallization of solids |
| RU2491096C9 (ru) * | 2007-09-13 | 2014-02-10 | Басф Се | Применение гидрофобин-полипептидов в качестве усилителя пенетрации |
| CN102089051A (zh) | 2008-07-11 | 2011-06-08 | 巴斯夫欧洲公司 | 作为形态学改变剂的两亲性蛋白质 |
-
2010
- 2010-02-19 JP JP2011551471A patent/JP5832302B2/ja not_active Expired - Fee Related
- 2010-02-19 US US13/202,112 patent/US8758730B2/en not_active Expired - Fee Related
- 2010-02-19 EP EP10704826.6A patent/EP2400988B1/en not_active Not-in-force
- 2010-02-19 WO PCT/EP2010/052125 patent/WO2010097344A1/en not_active Ceased
- 2010-02-19 CN CN201080009474.2A patent/CN102333546B/zh not_active Expired - Fee Related
- 2010-02-19 KR KR1020117022071A patent/KR20110130440A/ko not_active Withdrawn
- 2010-02-19 CA CA2784516A patent/CA2784516C/en not_active Expired - Fee Related
-
2012
- 2012-04-25 ZA ZA2012/03028A patent/ZA201203028B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012518669A5 (enExample) | ||
| JP2009268467A5 (enExample) | ||
| JP2013515057A5 (enExample) | ||
| HRP20140616T1 (hr) | Peptidni analog oksintomodulina | |
| JP2018504419A5 (enExample) | ||
| JP2018510622A5 (enExample) | ||
| JP2004529067A5 (enExample) | ||
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| JP2011502964A5 (enExample) | ||
| US10647742B2 (en) | Method for synthesizing etelcalcetide | |
| JP2013543497A5 (enExample) | ||
| JP2012505902A5 (enExample) | ||
| JP2005516072A5 (enExample) | ||
| JP2014506450A5 (enExample) | ||
| RU2017119773A (ru) | Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение | |
| AR079114A1 (es) | Proteinas de enlace de antigenos anti-orai1 y usos de las mismas | |
| WO2005098435A3 (en) | Peptides and peptidomimetics binding to cd23 | |
| JP2014510519A5 (enExample) | ||
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| TW201629085A (zh) | 芋螺毒素（ｃｏｎｏｔｏｘｉｎ）肽之修飾及用途 | |
| WO2011038900A3 (en) | Peptide analogues of glucagon for diabetes therapy | |
| WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
| JP2008521795A5 (enExample) | ||
| EA201100459A1 (ru) | Композиции, включающие интерлейкин-1 и пептиды | |
| WO2008113970A3 (en) | Peptides |